Markets:

Overview

News

Currencies

International

Treasuries

Lipocine Inc. - Common Stock (NQ:LPCN)

2.090 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lipocine Inc. - Common Stock

< Previous 1 2 3 Next >

Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket ↗

April 04, 2023

Gainers AMC Entertainment Hldg Pref Equity Units (NYSE: APE) gained 28.4% to $1.90 in pre-market trading. AMC Entertainment Holdings stated it agreed to settle litigation and move forward with...

Via Benzinga

Around $3M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

March 27, 2023

The Dow Jones closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Nogin And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

March 20, 2023

The Dow Jones traded higher by around 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 13, 2023

Via Benzinga

Lipocine To Focus On Central Nervous System Conditions; Explores Partnerships For Non-Core Assets ↗

September 26, 2022

Via Benzinga

Lipocine Posts Encouraging Data For Testosterone Prodrug In NASH Patients ↗

May 12, 2022

Via Benzinga

Antares Pharma's Oral Testosterone Treatment Scores FDA Approval ↗

March 29, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 23, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 23, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 10, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 07, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 19, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million.

Via Benzinga

Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary ↗

September 15, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 09, 2022

During Friday's session, 41 companies made new 52-week lows.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 18, 2022

It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

August 16, 2022

On Tuesday, 37 stocks hit new 52-week lows.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 11, 2022

Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch!

Via InvestorPlace

Recap: Lipocine Q2 Earnings ↗

August 08, 2022

Lipocine (NASDAQ:LPCN) reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Lipocine reported in-line EPS of...

Via Benzinga

Lipocine Gets FDA Nod For Mid-Stage Epilepsy Study ↗

July 11, 2022

The U.S. Food and Drug Administration (FDA) has accepted the Lipocine’s (NASDAQ: LPCN) Investigational New Drug Application (IND) for its candidate, LPCN 2101 in adults with epilepsy.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 11, 2022

Via Benzinga

4 Stocks Under $3 Insiders Are Aggressively Buying ↗

May 17, 2022

US crude oil futures traded slightly lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

7 Undervalued Penny Stocks With Major Upside ↗

March 29, 2022

Each of these penny stocks has proven momentum throughout 2022 and major upside on top of the returns through the the first quarter.

Via InvestorPlace

36 Stocks Moving In Tuesday's Mid-Day Session ↗

March 29, 2022

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 29, 2022

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 45.0% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $8.5 million.

Via Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

20 Stocks Moving in Tuesday's Pre-Market Session ↗

March 29, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) rose 40.1% to $21.00 in pre-market trading following announcement of collaboration with Sanofi (NASDAQ: SNY). Guardforce AI Co.,...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.